Zdrowie i gospodarka · 24/09/2019

FDA Clears Path for Atropine Sulfate Solution to be Used in New Drug Applications

The FDA has determined that the Atropine Sulfate Ansyr Plastic Syringe, used for intravenous, intramuscular, subcutaneous, and endotracheal administration, does not pose safety or effectiveness concerns, paving the way for the approval of abbreviated new drug applications for this product.